A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice

Alexa R Aubrey, Komal K Patel, Jesse M Hall, Mohamed M Shamseldin, Myra Guo, Gianni B DeLucia, Siddhi Shah, Kara N Corps, Rajendar Deora, Purnima Dubey · 2026

Read A BcfA-containing intranasal vaccine generated TH17 immunity and reduced B. bronchiseptica colonization and disease in mice by Alexa R Aubrey, Komal K Patel, Jesse M Hall, Mohamed M Shamseldin, Myra Guo, Gianni B DeLucia, Siddhi Shah, Kara N Corps, Rajendar Deora, Purnima Dubey (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13369460.txt.

Description

Alexa Aubrey and nine co-authors test a nose-delivered vaccine in mice in a study from two thousand twenty-six. The target is Bordetella bronchiseptica, a cause of respiratory disease in farm and companion animals. Current vaccines protect briefly and do not build strong mucosal immunity in the airways.

Their vaccine mixes three bacterial proteins, one of which also acts as an adjuvant. Given through the nose, it produced TH17 immune cells in the body and airways, plus antibodies in blood and mucus. Vaccinated mice were protected against weight loss, airway narrowing, and cough after challenge. The bacteria were cleared from the lungs and reduced in the nose. The authors see promise for longer protection in animals.

Catalog record

CREATORAlexa R Aubrey, Komal K Patel, Jesse M Hall, Mohamed M Shamseldin, Myra Guo, Gianni B DeLucia, Siddhi Shah, Kara N Corps, Rajendar Deora, Purnima Dubey
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13369460

Browse the full library · About the Tower of Babel